We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

176 hedge funds and large institutions have $72.4M invested in Definium Therapeutics in 2021 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 54 increasing their positions, 35 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $5.21M | Put options by funds: $2.36M

54% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 35

28% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 29

1% more funds holding

Funds holding: 174 → 176 (+2)

0.05% less ownership

Funds ownership: 0.87% → 0.82% (-0.05%)

31% less capital invested

Capital invested by funds: $105M → $72.4M (-$32.4M)

Holders
176
Holders Change
+2
Holders Change %
+1.15%
% of All Funds
2.71%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
37
Increased
54
Reduced
35
Closed
29
Calls
$5.21M
Puts
$2.36M
Net Calls
+$2.85M
Net Calls Change
+$1.65M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$4.69M
2
Citadel Advisors
Citadel Advisors
Florida
+$2.96M
3
Two Sigma Investments
Two Sigma Investments
New York
+$1.68M
4
BB
Busey Bank
Illinois
+$918K
5
BlackRock
BlackRock
New York
+$816K

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$1.68M
2
MI
MMCAP International
Cayman Islands
-$759K
3
Millennium Management
Millennium Management
New York
-$673K
4
Simplex Trading
Simplex Trading
Illinois
-$362K
5
SC
Shay Capital
New York
-$329K
Name Holding Trade Value Shares
Change 		Change in
Stake
TIM
126
Tortoise Investment Management
New York
$8K – – –
AFG
127
Albion Financial Group
Utah
$7K – – –
CAPTRUST Financial Advisors
128
CAPTRUST Financial Advisors
North Carolina
$7K +$1.56K +49 +18%
SC
129
SouthState Corp
Florida
$7K +$11.2K +352 New
CA
130
Clearstead Advisors
Ohio
$6K +$2.68K +84 +40%
SIC
131
SJS Investment Consulting
Ohio
$6K +$8.59K +269 New
KTC
132
Kistler-Tiffany Companies
Pennsylvania
$5K – – –
CWP
133
Concord Wealth Partners
Virginia
$5K +$7.47K +234 New
CCMIC
134
Cardinal Capital Management Inc (Canada)
Manitoba, Canada
$5K +$7.98K +250 New
SPIA
135
Steward Partners Investment Advisory
New York
$4K – – –
RI
136
Rinkey Investments
California
$4K +$8.52K +267 New
BAM
137
Baldrige Asset Management
Pennsylvania
$3K – – –
FRA
138
Front Row Advisors
California
$3K – – –
GWS
139
Glassman Wealth Services
Virginia
$3K – – –
PNC Financial Services Group
140
PNC Financial Services Group
Pennsylvania
$3K – – –
Rockefeller Capital Management
141
Rockefeller Capital Management
New York
$3K – – –
US Bancorp
142
US Bancorp
Minnesota
$3K – – –
TFM
143
TFC Financial Management
Massachusetts
$3K +$2.11K +66 +99%
HNWA
144
Henrickson Nauta Wealth Advisors
Michigan
$3K +$6.38K +200 New
BC
145
Burleson & Co
California
$2K – – –
ARMC
146
American Research & Management Company
Massachusetts
$1K – – –
AF
147
Arrow Financial
New York
$1K – – –
BCV
148
Banque Cantonale Vaudoise
Switzerland
$1K – – –
PK
149
Pflug Koory
Nebraska
$1K – – –
TCM
150
Tradewinds Capital Management
Washington
$1K – – –
4 5
6
7 8

DFTX Hedge Fund Activity: Q4 2021 in Review

176 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q4 2021, worth a combined $72.4M — down 31% from $105M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new DFTX positions and 29 closed out — a net gain of 8 holders — while 54 added to existing stakes and 35 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $4.69M. The largest seller was Goldman Sachs, cutting an estimated $1.68M.

  • 176 institutional investors held Definium Therapeutics (DFTX) as of Q4 2021, up from 174 in Q3 2021.
  • Funds reported $72.4M of Definium Therapeutics stock for Q4 2021, down 31% quarter-over-quarter.
  • 37 funds opened new Definium Therapeutics positions in Q4 2021 and 29 closed out, a net change of +8 holders.
  • The largest Definium Therapeutics buyer in Q4 2021 was Morgan Stanley, an estimated $4.69M added.
  • The largest Definium Therapeutics seller in Q4 2021 was Goldman Sachs, an estimated $1.68M sold.

Based on aggregated 13F filings for Q4 2021.